Generics BulletinIndian giant Biocon Limited has celebrated receiving local approval for its generic liraglutide, referencing Novo Nordisk’s Victoza. India’s Central Drugs Standard Control Organisation approved the ge
Generics BulletinMarking its first year of being a fully integrated biosimilars company , Biocon Biologics has a packed calendar with five launches expected over the next 12 to 18 months. These products include off-p
Generics BulletinBiocon Limited is looking to raise INR45bn ($526.95m), largely to meet debt obligations from the investment in its subsidiary Biocon Biologics. During the earnings call for the fiscal fourth quarter a
Generics BulletinTeva and Alvotech have celebrated receiving an interchangeability designation for their partnered Selarsdi (ustekinumab-aekn) biosimilar to Stelara in the US, allowing the product to be substituted at